Sheng Nuo Biotechnology (688117.SH): Peilaigajia's raw medicine obtains the notice of approval for listing application.

Zhtng Cijng APP News, Shngnu Shngw (688117.SH) announced that its wholly-owned subsidiary, Chengdu Shngnu Shngw Zhyo Yuxin Gngs, recently received the "Chemical Raw Material Drug Market Application Approval Notification" for Pei Lai Jia Nan raw materials issued by the National Medical Products Administration. Pei Lai Jia Nan spray is a topical antibacterial drug, a new class of peptide anti-infective drugs, suitable for the treatment of first-degree or superficial second-degree burns and subsequent wound infections caused by Staphylococcus epidermis, hemolytic Staphylococcus, and Pseudomonas aeruginosa. The launch of this drug provides patients with a new treatment option.